Pricing Log in Create free account

Orgenesis Inc. (ORGS) vs Traws Pharma, Inc. (TRAW)

Orgenesis Inc. and Traws Pharma, Inc. are both Biotechnology companies. Orgenesis Inc. and Traws Pharma, Inc. are of similar size ($6.2M and $5.7M). Traws Pharma, Inc. grew revenue faster over the last twelve months: 1,159.3% against 95.3%. Traws Pharma, Inc. has the higher net margin (0.00% vs −4,653.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Traws Pharma, Inc. leads on 12 and Orgenesis Inc. on 4.

Valuation

Metric ORGS TRAW Biotechnology median
P/E n/m n/m 8.50
P/S 0.24 2.06 9.71
P/B n/m 3.47 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 15.71 0.30 9.21
Earnings yield (19,183.33%) (475.68%) (33.15%)
Free cash flow yield (6,862.91%) (287.29%) (25.50%)

Profitability

Metric ORGS TRAW Biotechnology median
Gross margin (86.28%) 100.00% 65.16%
Operating margin (3,842.32%) 0.00% 0.00%
Net margin (4,653.62%) 0.00% 0.00%
Free cash flow margin (1,675.27%) 0.00% 0.00%
Return on equity 164.62% (319.42%) (56.36%)
Return on assets (605.73%) (117.35%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ORGS TRAW Biotechnology median
Revenue growth (TTM) 95.28% 1,159.29% 6.02%
EPS growth (last fiscal year) 40.10% 100.76% 30.26%
Revenue growth, 5-year CAGR (23.30%) 64.59% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ORGS TRAW Biotechnology median
Debt to equity (0.44) 0.00 0.00
Current ratio 0.03 0.93 4.72
Net debt to EBITDA (0.42) 0.21 0.96

Dividend

Metric ORGS TRAW Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ORGS TRAW Biotechnology median
Market cap 5.68m 6.20m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack